Cargando…
Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868285/ https://www.ncbi.nlm.nih.gov/pubmed/35204198 http://dx.doi.org/10.3390/antiox11020314 |
_version_ | 1784656231313440768 |
---|---|
author | Musheshe, Nshunge Oun, Asmaa Sabogal-Guáqueta, Angélica María Trombetta-Lima, Marina Mitchel, Sarah C. Adzemovic, Ahmed Speek, Oliver Morra, Francesca van der Veen, Christina H. J. T. Lezoualc’h, Frank Cheng, Xiaodong Schmidt, Martina Dolga, Amalia M. |
author_facet | Musheshe, Nshunge Oun, Asmaa Sabogal-Guáqueta, Angélica María Trombetta-Lima, Marina Mitchel, Sarah C. Adzemovic, Ahmed Speek, Oliver Morra, Francesca van der Veen, Christina H. J. T. Lezoualc’h, Frank Cheng, Xiaodong Schmidt, Martina Dolga, Amalia M. |
author_sort | Musheshe, Nshunge |
collection | PubMed |
description | Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerative diseases. The role of Epac modulation in neuronal cells in relation to cell survival and death, as well as its potential effect on mitochondrial function, is not well established. In immortalized hippocampal (HT-22) neuronal cells, we examined mitochondria function in the presence of various Epac pharmacological modulators in response to oxidative stress due to ferroptosis. Our study revealed that selective pharmacological modulation of Epac1 or Epac2 isoforms, exerted differential effects in erastin-induced ferroptosis conditions in HT-22 cells. Epac1 inhibition prevented cell death and loss of mitochondrial integrity induced by ferroptosis, while Epac2 inhibition had limited effects. Our data suggest Epac1 as a plausible therapeutic target for preventing ferroptosis cell death associated with neurodegenerative diseases. |
format | Online Article Text |
id | pubmed-8868285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88682852022-02-25 Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity Musheshe, Nshunge Oun, Asmaa Sabogal-Guáqueta, Angélica María Trombetta-Lima, Marina Mitchel, Sarah C. Adzemovic, Ahmed Speek, Oliver Morra, Francesca van der Veen, Christina H. J. T. Lezoualc’h, Frank Cheng, Xiaodong Schmidt, Martina Dolga, Amalia M. Antioxidants (Basel) Article Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerative diseases. The role of Epac modulation in neuronal cells in relation to cell survival and death, as well as its potential effect on mitochondrial function, is not well established. In immortalized hippocampal (HT-22) neuronal cells, we examined mitochondria function in the presence of various Epac pharmacological modulators in response to oxidative stress due to ferroptosis. Our study revealed that selective pharmacological modulation of Epac1 or Epac2 isoforms, exerted differential effects in erastin-induced ferroptosis conditions in HT-22 cells. Epac1 inhibition prevented cell death and loss of mitochondrial integrity induced by ferroptosis, while Epac2 inhibition had limited effects. Our data suggest Epac1 as a plausible therapeutic target for preventing ferroptosis cell death associated with neurodegenerative diseases. MDPI 2022-02-04 /pmc/articles/PMC8868285/ /pubmed/35204198 http://dx.doi.org/10.3390/antiox11020314 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Musheshe, Nshunge Oun, Asmaa Sabogal-Guáqueta, Angélica María Trombetta-Lima, Marina Mitchel, Sarah C. Adzemovic, Ahmed Speek, Oliver Morra, Francesca van der Veen, Christina H. J. T. Lezoualc’h, Frank Cheng, Xiaodong Schmidt, Martina Dolga, Amalia M. Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title | Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title_full | Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title_fullStr | Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title_full_unstemmed | Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title_short | Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity |
title_sort | pharmacological inhibition of epac1 averts ferroptosis cell death by preserving mitochondrial integrity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868285/ https://www.ncbi.nlm.nih.gov/pubmed/35204198 http://dx.doi.org/10.3390/antiox11020314 |
work_keys_str_mv | AT musheshenshunge pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT ounasmaa pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT sabogalguaquetaangelicamaria pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT trombettalimamarina pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT mitchelsarahc pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT adzemovicahmed pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT speekoliver pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT morrafrancesca pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT vanderveenchristinahjt pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT lezoualchfrank pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT chengxiaodong pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT schmidtmartina pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity AT dolgaamaliam pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity |